The log-rank test showed a borderline significant difference ( p = 0.06).
← all phrases
“borderline significant”
Sighted at
p=0.09
In the literature
However, the trends in the nonlinear relationship were attenuated when subjects were divided according to PI at 120 min (Figure 3 A), although borderline significant was observed between lean subjects and obese subjects (two-way ANOVA, P = 0.06, Figure 3 B).
With these variables in the model, heritability in RJA performance was reduced and only borderline significant (h 2 = .228, s.e. = .152, p < .06).
The study showed a borderline significant improvement in progression free survival (PFS) in the combination arm compared with ADT alone (HR =0.75, 95% CI, 0.55-1.01; P=0.06).
The difference between age groups was significant for all strains (p<0.01), but in post-hoc analysis the difference in ε T between the middle and oldest age groups was only borderline significant (p=0.06).
first quintile of the Western pattern had a significant increased risk (Hazard ratio, 95% confidence interval: 1.11, 1.01–1.23) of fractures, and there was a borderline significant positive trend ( p = 0.06).
When compared to the nIBC cohort, this decrease was significantly higher in TN IBC ( p = 0.007), borderline significant ( p = 0.06) in the HR+ IBC and not significant in HER2+ IBC ( p = 0.37).
The difference in IL-6 production was borderline significant with regards to spontaneous production and bDMARD (P = 0.06).
Correction for multiple comparisons and sensitivity analysis using non-parametric tests When performing significance level adjustment to post-hoc analyzes using the conservative Sidak method, results remained significant for all outcomes except for IMI within group change for Cz MRCP which became borderline significant ( P = 0.06) and between group changes for IMI vs.
In a previous study 4 , a borderline significant relationship was found between mild COPD and CKD, while moderate COPD had a higher risk of CKD (mild COPD and CKD: OR: 1.23, 95% CI, 0.99-1.53, P = 0.06; moderate COPD and CKD: 1.33, 95% CI, 1.07-1.65, P = 0.01) and no significant association was found between severe COPD and CKD.
Mobile phone users were found to have a higher awareness of risk factors of breast cancer ( P< 0.001), whereas the association with risk awareness of cervical cancer was borderline significant ( P= 0.06).
However, when comparing virally suppressed HIV seropositive (VL <20 copies/mL) with HIV seronegative men, there remained significant increases in indexed LV mass (β=2.97 [95% CI, 0.31–5.63], P =0.029), LA diameter (β=0.08 [95% CI, 0.02–0.14], P =0.012), and indexed LA area (β=0.27 [95% CI, 0.06–0.48], P =0.011) as well as decreased mitral e’ velocity (β=−0.42 [−0.70 to −0.14], P =0.004) and increased E/e’ ratio (β=0.34, [95% CI, 0.03–0.66], P =0.033) and a borderline significant increased prevalence of DD (odds ratio 1.40 [95% CI, 0.99–2.00], P =0.06).
Although the correlation was not significant, the squatting subscore was borderline significant correlated with both LPD (r = 0.30, P = 0.06) and LPD/HT (r = 0.27 and P = 0.09).
Among the 20 eyes with Schirmer testing, there was a borderline significant increase in score from baseline to follow-up (5.9 vs 9.7, p = 0.06).
There was a borderline significant association between ever use of oestrogen-containing hormone replacement therapy (HRT) and mortality (HR=0.79; 95% CI 0.62–1.01; P =0.06).
Moreover, there was a significantly higher concentration in TIF in stages I and II compared to III and IV (p = 0.019), whereas this relationship was opposite, and borderline significant in plasma (p = 0.06).
RNI was also associated with a borderline significant reduction of LRR (3-year LRR rate 4.2% vs 8.1%, P = 0.06).
Results of linear multiple regression adjusted for age, sex, BMI, and pain score demonstrated a borderline significant correlation between age (r = 0.32, p = 0.06), and the change in PV after running, suggesting that higher age was associated with less reduction in PV.
BMI and plasma insulin showed a significant ( P < 0.04) shared genetic component with plasma adiponectin of, respectively, −32.4 and −20.0%, whereas our finding for HOMA-IR was borderline significant (genetic correlation [ρ G ] = −18.6%, P = 0.06).
RESULTS: Permeability analysis across all groups demonstrated significant difference among the groups for 0–2 hours 13 C-mannitol, 0–24 hours 13 C-mannitol, and borderline significant difference for 2–8 hours 13 C-mannitol ( P = 0.060) and 0–24 hours lactulose ( P = 0.056).
A notable increase in BALF KC was also apparent in mice treated with ‘inflammatory’ MVs, although this was only borderline significant (p=0.06).
When compared with the sedation group, patients under GA had a relative risk of 0.62 to have gastrointestinal perforation, and this difference was borderline significant (RR 0.62; 95% CI: 0.21–1.82; I 2 = 52%; P = 0.06) ( Figure 4A ).
After accounting for maternal race/ethnicity, education, maternal age at delivery, newborn’s gender and gestational age at birth, these associations were borderline significant (β = 1.57, SE = 0.82, P = 0.06).
There was a borderline significant increase in G3/4 diarrhoea (OR: 1.75, p = 0.06), but no effect on treatment discontinuation without progression (OR: 0.87, p = 0.25).
Having a metachronous primary lung cancer was borderline significant for a higher LPFS (p = 0.06).